Seminars in Hematology
Volume 47, Issue 2 , Pages 143-147, April 2010

Treatment of Splenic Marginal Zone Lymphoma: Splenectomy Versus Rituximab

  • Michael Bennett

      Affiliations

    • Department of Hematology, Ha'Emek Medical Center, Afula, Israel
    • ,
  • Geraldine P. Schechter

      Affiliations

    • Hematology Section, Veterans Affairs Medical Center, and George Washington University, Washington, DC
    • Corresponding Author InformationAddress correspondence to Geraldine P. Schechter, MD, Hematology Section, Veterans Affairs Medical Center, George Washington University, Washington, DC 20422

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(10)00005-3

doi:10.1053/j.seminhematol.2010.01.004

Seminars in Hematology
Volume 47, Issue 2 , Pages 143-147, April 2010

Article Tools